{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T01:12:13Z","timestamp":1761181933349,"version":"build-2065373602"},"reference-count":75,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R21DA061660"],"award-info":[{"award-number":["R21DA061660"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute On Drug Abuse of the National Institutes of Health","award":["5R01DA047994"],"award-info":[{"award-number":["5R01DA047994"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>\n                    Amid the ongoing overdose crisis, U.S. lawmakers are considering policy reforms that could significantly change availability and accessibility of methadone treatment (MT) for opioid use disorder (OUD). However, uncertainty remains about which potential changes will lead to the greatest health benefits while minimizing unintended harms. In this protocol, we describe a planned NIH-funded study\n                    <jats:italic>\n                      <jats:italic>(R21DA061660)<\/jats:italic>\n                    <\/jats:italic>\n                    to simulate alternative MT delivery scenarios currently being considered in U.S. policy discussions, and estimate their impact on population-level rates of treatment initiation and retention and opioid overdose across different sociodemographic groups. We will use an agent-based model focused on 16 counties in NY State to simulate two alternative policy scenarios compared to the current status quo of opioid-treatment program (OTP) delivered MT: 1) office-based prescribing by addiction-certified providers with pharmacy and OTP dispensing; and 2) office-based prescribing by general practitioners with pharmacy and OTP dispensing. Agents will represent individuals with OUD and we will simulate access to MT based on alternative policy scenarios (e.g., locations of existing OTPs vs. provider offices and pharmacies). Probabilities of treatment initiation, retention, and opioid overdose will be informed by estimates from the scientific literature and administrative datasets from NY State. Multiple implementation scenarios will be considered to account for potential variation in adoption of office-based methadone by patients, providers, and pharmacies. To ensure relevance to directly impacted communities and policy makers, the study involves a collaboration between academic researchers and NY State government partners and relies on input from an Expert Advisory Board of people with lived and living experience with methadone, addiction medicine, and policy experts. Findings will be disseminated via a public dashboard. This study will inform ongoing policy discussions and shed light on the potential of researcher-policy partnerships to promote evidence-based policies that can reduce overdose and improve population health.\n                  <\/jats:p>","DOI":"10.1371\/journal.pone.0335123","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:34:50Z","timestamp":1761154490000},"page":"e0335123","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Simulating the impact of methadone prescribing and pharmacy dispensing on opioid treatment and overdose in New York State: A study protocol for an agent-based modeling study"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7396-3938","authenticated-orcid":true,"given":"Noa","family":"Krawczyk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3746-578X","authenticated-orcid":true,"given":"Ignacio","family":"B\u00f3rquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Rutherford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgiy","family":"Bobashev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela","family":"Mund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Keyes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Cerd\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashly E.","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"key":"pone.0335123.ref001","volume-title":"Natl. Cent. Health Stat.","author":"U.S. Overdose Deaths Decrease Almost 27% in 2024 [Internet].","year":"2025"},{"key":"pone.0335123.ref002","article-title":"Provisional drug overdose death counts [Internet]. Natl. Cent. Health Stat","author":"F Ahmad","year":"2025","journal-title":"Available from"},{"key":"pone.0335123.ref003","doi-asserted-by":"crossref","DOI":"10.17226\/25310","volume-title":"Medications for Opioid Use Disorder Save Lives [Internet","author":"AI Leshner","year":"2019"},{"issue":"2","key":"pone.0335123.ref004","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/HRP.0000000000000075","article-title":"Medication-assisted treatment of opioid use disorder: review of the evidence and future directions","volume":"23","author":"HS Connery","year":"2015","journal-title":"Harv Rev Psychiatry"},{"key":"pone.0335123.ref005","article-title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies","volume":"357","author":"L Sordo","year":"2017","journal-title":"BMJ"},{"issue":"9","key":"pone.0335123.ref006","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/jamapsychiatry.2021.0976","article-title":"Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid Dependence: A Systematic Review and Meta-analysis","volume":"78","author":"Jr Santo T","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"pone.0335123.ref007","doi-asserted-by":"crossref","first-page":"103786","DOI":"10.1016\/j.drugpo.2022.103786","article-title":"Has the treatment gap for opioid use disorder narrowed in the U.S.?: A yearly assessment from 2010 to 2019\"","volume":"110","author":"N Krawczyk","year":"2022","journal-title":"Int J Drug Policy"},{"key":"pone.0335123.ref008","volume-title":"National Survey Of Substance Abuse Treatment Services (N-SSATS): 2020, Data On Substance Abuse Treatment Facilities [Internet].","author":"Substance Abuse and Mental Health Services Administration","year":"2021"},{"key":"pone.0335123.ref009","unstructured":"Bromley L, Kahan M, Regenstreif L, Srivastava A, Wyman J. Methadone treatment for people who use fentanyl: Recommendations [Internet]. Toronto, ON: META:PHI; 2021. Available from: www.metaphi.ca"},{"key":"pone.0335123.ref010","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.drugalcdep.2018.07.019","article-title":"Methadone maintenance treatment among patients exposed to illicit fentanyl in Rhode Island: Safety, dose, retention, and relapse at 6 months","volume":"192","author":"AC Stone","year":"2018","journal-title":"Drug Alcohol Depend"},{"key":"pone.0335123.ref011","volume-title":"Federal Regulation of Methadone Treatment [Internet","author":"RA Rettig","year":"1995"},{"key":"pone.0335123.ref012","unstructured":"Dooling BCE, Stanley L. Unsupervised Use of Opioid Treatment Medications [Internet]. George Washington University; 2021. Report No.: II. Available from: https:\/\/regulatorystudies.columbian.gwu.edu\/unsupervised-use-opioid-treatment-medications"},{"key":"pone.0335123.ref013","unstructured":"Opioid Treatment Programs: A Key Treatment System Component [Internet]. Pew Charit. Trusts. 2021 [cited 2024 Jun 12]. Available from: https:\/\/pew.org\/3AVbDPo"},{"key":"pone.0335123.ref014","unstructured":"Duff JH, Carter JA. Location of Medication-Assisted Treatment for Opioid Addiction: In Brief [Internet]. Congressional Research Service; 2019 Jun. Report No.: R45782. Available from: https:\/\/sgp.fas.org\/crs\/misc\/R45782.pdf"},{"issue":"13","key":"pone.0335123.ref015","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1001\/jama.2019.12562","article-title":"Drive Times to Opioid Treatment Programs in Urban and Rural Counties in 5 US States","volume":"322","author":"PJ Joudrey","year":"2019","journal-title":"JAMA"},{"issue":"11","key":"pone.0335123.ref016","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1001\/jamapsychiatry.2020.1624","article-title":"Comparison of Driving Times to Opioid Treatment Programs and Pharmacies in the US","volume":"77","author":"RA Kleinman","year":"2020","journal-title":"JAMA Psychiatry"},{"key":"pone.0335123.ref017","unstructured":"Substance Abuse and Mental Health Services Administration. Federal Guidelines for Opioid Treatment Programs. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2015 Jan. Report No.: HHS Publication No. (SMA) PEP15-FEDGUIDEOTP."},{"key":"pone.0335123.ref018","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jsat.2018.10.006","article-title":"Evidence-based treatment for opioid use disorders: A national study of methadone dose levels, 2011\u20132017","volume":"96","author":"T D\u2019Aunno","year":"2019","journal-title":"J Subst Abuse Treat"},{"issue":"1","key":"pone.0335123.ref019","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12954-021-00535-y","article-title":"\u201cIt\u2019s like 'liquid handcuffs\u201d: The effects of take-home dosing policies on Methadone Maintenance Treatment (MMT) patients\u2019 lives","volume":"18","author":"D Frank","year":"2021","journal-title":"Harm Reduct J"},{"key":"pone.0335123.ref020","doi-asserted-by":"crossref","DOI":"10.2105\/AJPH.2021.306665","article-title":"The Methadone Manifesto: Treatment Experiences and Policy Recommendations From Methadone Patient Activists","volume":"112","author":"C Simon","year":"2022","journal-title":"Am J Public Health"},{"issue":"6","key":"pone.0335123.ref021","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1177\/1049732311432718","article-title":"Methadone as social control: institutionalized stigma and the prospect of recovery","volume":"22","author":"J Harris","year":"2012","journal-title":"Qual Health Res"},{"issue":"4","key":"pone.0335123.ref022","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.3711","article-title":"Association of Racial\/Ethnic Segregation With Treatment Capacity for Opioid Use Disorder in Counties in the United States","volume":"3","author":"WC Goedel","year":"2020","journal-title":"JAMA Netw Open"},{"key":"pone.0335123.ref023","unstructured":"Roberts S. The Politics of Stigma and Racialization in the Early Years of Methadone Maintenance Regulation [Internet]. National Academy of Sciences; 2022. Available from: https:\/\/www.nationalacademies.org\/documents\/embed\/link\/LF2255DA3DD1C41C0A42D3BEF0989ACAECE3053A6A9B\/file\/D4F35602BCE0AD3C6FCAD4515932EF817FD6D4CB9791?noSaveAs=1"},{"issue":"3","key":"pone.0335123.ref024","doi-asserted-by":"crossref","DOI":"10.1016\/S2468-2667(23)00023-3","article-title":"Synthesising evidence of the effects of COVID-19 regulatory changes on methadone treatment for opioid use disorder: implications for policy","volume":"8","author":"N Krawczyk","year":"2023","journal-title":"Lancet Public Health"},{"key":"pone.0335123.ref025","article-title":"To save lives from opioid overdose deaths, bring methadone into mainstream medicine","author":"Z Adams","year":"2022","journal-title":"Health Aff"},{"issue":"6","key":"pone.0335123.ref026","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s11606-018-4801-3","article-title":"Methadone Matters: What the United States Can Learn from the Global Effort to Treat Opioid Addiction","volume":"34","author":"SL Calcaterra","year":"2019","journal-title":"J Gen Intern Med"},{"key":"pone.0335123.ref027","unstructured":"Senators Markey and Paul Introduce Bipartisan Legislation to Modernize, Improve Methadone Treatment Amid Skyrocketing Opioid Overdoses and Deaths [Internet]. 2022 [cited 2024 Jun 12]. Available from: https:\/\/www.markey.senate.gov\/news\/press-releases\/senators-markey-and-paul-introduce-bipartisan-legislation-to-modernize-improve-methadone-treatment-amid-skyrocketing-opioid-overdoses-and-deaths"},{"key":"pone.0335123.ref028","unstructured":"Fiellin D. Office-Based Methadone versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment \u2013 A Randomized Pragmatic Hybrid Effectiveness\/Implementation Trial | National Institute on Drug Abuse (NIDA) [Internet]. Natl. Inst. Drug Abuse. 2021 [cited 2025 Sep 4]. Available from: https:\/\/nida.nih.gov\/about-nida\/organization\/cctn\/ctn\/research-studies\/office-based-methadone-versus-buprenorphine-to-address-retention-in-medication-opioid-use-disorder"},{"issue":"4","key":"pone.0335123.ref029","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jsat.2006.05.018","article-title":"A 5-year evaluation of a methadone medical maintenance program","volume":"31","author":"Jr Harris KA","year":"2006","journal-title":"J Subst Abuse Treat"},{"key":"pone.0335123.ref030","doi-asserted-by":"crossref","unstructured":"Tuchman E, Gregory C, Simson M, Drucker E. Safety, Efficacy, and Feasibility of Office-based Prescribing and Community Pharmacy Dispensing of Methadone: Results of a Pilot Study in New Mexico. Addict Disord Their Treat [Internet]. 2006 [cited 2025 Jul 22];5:43. Available from: https:\/\/journals.lww.com\/addictiondisorders\/fulltext\/2006\/06000\/safety,_efficacy,_and_feasibility_of_office_based.1.aspx","DOI":"10.1097\/01.adt.0000210713.80198.d1"},{"issue":"2","key":"pone.0335123.ref031","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/add.15641","article-title":"Opioid treatment program and community pharmacy collaboration for methadone maintenance treatment: results from a feasibility clinical trial","volume":"117","author":"L-T Wu","year":"2022","journal-title":"Addiction"},{"issue":"3","key":"pone.0335123.ref032","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/BF02600025","article-title":"Outcomes of treatment of socially rehabilitated methadone maintenance patients in physicians\u2019 offices (medical maintenance): follow-up at three and a half to nine and a fourth years","volume":"9","author":"DM Novick","year":"1994","journal-title":"J Gen Intern Med"},{"key":"pone.0335123.ref033","first-page":"388","article-title":"Methadone medical maintenance (MMM): treating chronic opioid dependence in private medical practice--a summary report (1983-1998)","volume":"67","author":"EA Salsitz","year":"2000","journal-title":"Mt Sinai J Med"},{"key":"pone.0335123.ref034","doi-asserted-by":"crossref","first-page":"107968","DOI":"10.1016\/j.drugalcdep.2020.107968","article-title":"Pharmacy-based methadone dispensing and drive time to methadone treatment in five states within the United States: A cross-sectional study","volume":"211","author":"PJ Joudrey","year":"2020","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"pone.0335123.ref035","article-title":"Methadone prescribing by addiction specialists likely to leave communities without available methadone treatment","volume":"1","author":"PJ Joudrey","year":"2023","journal-title":"Health Aff Sch"},{"key":"pone.0335123.ref036","unstructured":"Facher L. Providers of methadone treatment say a big increase in access could backfire [Internet]. STAT. 2022 [cited 2024 Jun 17]. Available from: https:\/\/www.statnews.com\/2022\/11\/03\/providers-of-methadone-treatment-say-a-big-increase-in-access-could-backfire\/"},{"issue":"1","key":"pone.0335123.ref037","article-title":"Recent modifications to the US methadone treatment system are a Band-Aid-not a solution-to the nation\u2019s broken opioid use disorder treatment system","volume":"1","author":"N Krawczyk","year":"2023","journal-title":"Health Aff Sch"},{"issue":"1","key":"pone.0335123.ref038","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/aje\/kwn118","article-title":"A new tool for epidemiology: the usefulness of dynamic-agent models in understanding place effects on health","volume":"168","author":"AH Auchincloss","year":"2008","journal-title":"Am J Epidemiol"},{"key":"pone.0335123.ref039","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1146\/annurev-publhealth-040617-014317","article-title":"Agent-Based Modeling in Public Health: Current Applications and Future Directions","volume":"39","author":"M Tracy","year":"2018","journal-title":"Annu Rev Public Health"},{"key":"pone.0335123.ref040","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.2105\/AJPH.2011.300149","article-title":"Complex systems thinking and current impasses in health disparities research","volume":"101","author":"AV Diez Roux","year":"2011","journal-title":"Am J Public Health"},{"key":"pone.0335123.ref041","article-title":"Simulating the simultaneous impact of medication for opioid use disorder and naloxone on opioid overdose death in eight New York counties","author":"M Cerd\u00e1","year":"2024","journal-title":"Epidemiol Camb Mass"},{"key":"pone.0335123.ref042","unstructured":"Borges M, Sipple JW. A report on recent changes in the population, demographics, housing, and income characteristics of Rural New York State (2011-2020). 2021."},{"issue":"1","key":"pone.0335123.ref043","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13722-025-00592-9","article-title":"Spatial accessibility of substance use disorder treatment programs, compared with other health care facilities, in New York State, 2024","volume":"20","author":"MA Bachhuber","year":"2025","journal-title":"Addict Sci Clin Pract"},{"key":"pone.0335123.ref044","doi-asserted-by":"crossref","unstructured":"Jordan AE, Zhang W, Gorry S, Heck A, Burke C, Cunningham CO. A Spatial Epidemiologic Analysis of Opioid Use Disorder Treatment in New York State. Med Care [Internet]. 2025 [cited 2025 Sep 4];63:386. Available from: https:\/\/journals.lww.com\/lww-medicalcare\/abstract\/2025\/05000\/a_spatial_epidemiologic_analysis_of_opioid_use.10.aspx","DOI":"10.1097\/MLR.0000000000002142"},{"key":"pone.0335123.ref045","doi-asserted-by":"crossref","first-page":"108335","DOI":"10.1016\/j.drugalcdep.2020.108335","article-title":"The HEALing (Helping to End Addiction Long-term SM) Communities Study: Protocol for a cluster randomized trial at the community level to reduce opioid overdose deaths through implementation of an integrated set of evidence-based practices","volume":"217","author":"Consortium HEALing Communities Study","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"pone.0335123.ref046","unstructured":"DEA - Qualifying Practitioners by State [Internet]. [cited 2024 Jun 17]. Available from: https:\/\/apps.deadiversion.usdoj.gov\/RAPR\/raprQualifyingPractitionersByState.xhtml#no-back-button"},{"key":"pone.0335123.ref047","unstructured":"Miller M, Krawczyk N. Methadone Diversion and Overdose: What Does the Evidence Say? A Narrative Review. Available from: Under Review"},{"key":"pone.0335123.ref048","volume-title":"Agent-Based and Individual-Based Modeling: A Practical Introduction","author":"SF Railsback","year":"2012"},{"key":"pone.0335123.ref049","unstructured":"Data [Internet]. Off. Addict. Serv. Supports. [cited 2025 Sep 4]. Available from: https:\/\/oasas.ny.gov\/data"},{"key":"pone.0335123.ref050","unstructured":"American Medical Association Physicians List [Internet]. MMS Inc Med. Mark. Serv. Inc. [cited 2025 Sep 4]. Available from: https:\/\/www.mmslists.com\/ama-physicians-list"},{"key":"pone.0335123.ref051","unstructured":"Buprenorphine Treatment Locator for Opioid Dependency [Internet]. Subst. Abuse Ment. Health Serv. Adm. 2024 [cited 2025 Sep 4]. Available from: https:\/\/www.samhsa.gov\/substance-use\/treatment\/find-treatment\/buprenorphine-practitioner-locator"},{"key":"pone.0335123.ref052","unstructured":"New York State Department of Health. Medicaid Enrolled Provider Listing [Internet]. [cited 2025 Sep 4]. Available from: https:\/\/health.data.ny.gov\/Health\/Medicaid-Enrolled-Provider-Listing\/keti-qx5t\/about_data"},{"key":"pone.0335123.ref053","unstructured":"IQVIA. Xponent Database [Internet]. [cited 2025 Sep 4]. Available from: https:\/\/www.iqvia.com\/locations\/united-states\/solutions\/life-sciences\/information-solutions\/essential-information\/real-world-data"},{"key":"pone.0335123.ref054","author":"HCUP State Inpatient Databases (SID).","year":"2019"},{"key":"pone.0335123.ref055","unstructured":"Restricted-Use Vital Statistics Data [Internet]. 2023 [cited 2025 Sep 4]. Available from: https:\/\/www.cdc.gov\/nchs\/nvss\/nvss-restricted-data.htm"},{"key":"pone.0335123.ref056","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41597-025-04380-7","article-title":"A National Synthetic Populations Dataset for the United States","volume":"12","author":"J Rineer","year":"2025","journal-title":"Scientific Data"},{"key":"pone.0335123.ref057","volume-title":"NetLogo [Internet]. Evanston, IL: Center for Connected Learning and Computer-Based Modeling","author":"U Wilensky","year":"1999"},{"key":"pone.0335123.ref058","unstructured":"R: The R Foundation [Internet]. [cited 2025 Sep 4]. Available from: https:\/\/www.r-project.org\/foundation\/"},{"issue":"9","key":"pone.0335123.ref059","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1176\/appi.ajp.2021.20101548","article-title":"Office-Based Methadone Treatment for Opioid Use Disorder and Pharmacy Dispensing: A Scoping Review","volume":"178","author":"D McCarty","year":"2021","journal-title":"Am J Psychiatry"},{"issue":"9","key":"pone.0335123.ref060","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1001\/jamapsychiatry.2022.1776","article-title":"Methadone-Involved Overdose Deaths in the US Before and After Federal Policy Changes Expanding Take-Home Methadone Doses From Opioid Treatment Programs","volume":"79","author":"CM Jones","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"pone.0335123.ref061","doi-asserted-by":"crossref","first-page":"100403","DOI":"10.1016\/j.imu.2020.100403","article-title":"Spatio-temporal simulation of the novel coronavirus (COVID-19) outbreak using the agent-based modeling approach (case study: Urmia, Iran)","volume":"20","author":"N Mahdizadeh Gharakhanlou","year":"2020","journal-title":"Inform Med Unlocked"},{"key":"pone.0335123.ref062","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1111\/j.1360-0443.2012.03960.x","article-title":"Commentary on Boyd et al: Debunking Myths about Methadone and Crime","volume":"107","author":"A Nunn","year":"2012","journal-title":"Addict Abingdon Engl"},{"key":"pone.0335123.ref063","unstructured":"Facher L. The fight for control of methadone, addiction treatment\u2019s \u2018miracle molecule\u2019 [Internet]. STAT. 2023 [cited 2025 Jul 23]. Available from: https:\/\/www.statnews.com\/2023\/10\/20\/methadone-clinic-access-prescription\/"},{"key":"pone.0335123.ref064"},{"key":"pone.0335123.ref065"},{"key":"pone.0335123.ref066"},{"key":"pone.0335123.ref067","doi-asserted-by":"crossref","first-page":"7","DOI":"10.18564\/jasss.4259","article-title":"The ODD Protocol for Describing Agent-Based and Other Simulation Models: A Second Update to Improve Clarity, Replication, and Structural Realism","volume":"23","author":"V Grimm","year":"2020","journal-title":"J Artif Soc Soc Simul"},{"key":"pone.0335123.ref068","doi-asserted-by":"crossref","first-page":"112548","DOI":"10.1016\/j.drugalcdep.2025.112548","article-title":"Opioid use disorder prevalence in 57 New York counties from 2017 to 2019: A Bayesian evidence synthesis","volume":"267","author":"T Zheng","year":"2025","journal-title":"Drug Alcohol Depend"},{"key":"pone.0335123.ref069"},{"key":"pone.0335123.ref070"},{"key":"pone.0335123.ref071"},{"key":"pone.0335123.ref072"},{"key":"pone.0335123.ref073"},{"key":"pone.0335123.ref074"},{"key":"pone.0335123.ref075"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0335123","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:34:58Z","timestamp":1761154498000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0335123"}},"subtitle":[],"editor":[{"given":"Katherine Demi","family":"Kokkinias","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":75,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0335123","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,22]]}}}